LR-510444

CAS No. 1233948-35-0

LR-510444( ELR510444 | ELR-510444 | ELR 510444. )

Catalog No. M10927 CAS No. 1233948-35-0

ELR510444 is a novel microtubule disruptor; inhibits MDA-MB-231 cell proliferation with IC50 of 30.9 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 35 In Stock
5MG 58 In Stock
10MG 87 In Stock
25MG 176 In Stock
50MG 332 In Stock
100MG 478 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    LR-510444
  • Note
    Research use only, not for human use.
  • Brief Description
    ELR510444 is a novel microtubule disruptor; inhibits MDA-MB-231 cell proliferation with IC50 of 30.9 nM.
  • Description
    ELR510444 is a novel microtubule disruptor; inhibits MDA-MB-231 cell proliferation with IC50 of 30.9 nM; not a substrate for the P-glycoprotein drug transporter and retains activity in βIII-tubulin-overexpressing cell lines.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ELR510444 | ELR-510444 | ELR 510444.
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    Microtubule/Tubulin
  • Recptor
    Microtubule disruptor
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1233948-35-0
  • Formula Weight
    368.47
  • Molecular Formula
    C19H16N2O2S2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    O=S(C1=CC=C(C)C=C1)(NC2=CC(C3=CC=C(C#N)S3)=CC=C2C)=O
  • Chemical Name
    N-(5-(5-cyanothiophen-2-yl)-2-methylphenyl)-4-methylbenzenesulfonamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Risinger AL, et al. J Pharmacol Exp Ther. 2011 Mar;336(3):652-60.
molnova catalog
related products
  • Avanbulin

    Avanbulin (BAL27862, BAL-27862) is a novel microtubule-destabilizing agent that potently inhibits tubulin assembly at 37°C with IC50 of 1.4 uM in tubulin-binding assays.

  • 6-MOMIPP

    6-MOMIPP is a novel microtubule disruptor that targets the colchicine binding site on β-tubulin, induces mitotic arrest, caspase activation and loss of cell viability of U251 glioblastoma in vitro.

  • Taccalonolide B

    Taccalonolide B is effective in vitro against cell lines that overexpress P-glycoprotein (Pgp) and multidrug-resistance protein (MRP7).?Taccalonolide B inhibits growth of SK-OV-3 cells with an IC50 of 208 nM.The structures were elucidated using a combination of spectroscopic methods, including 1D and 2D NMR and HR-ESI-MS.